Replies to post #194362 on Biotech Values

[oldberkeley]

KITE CC Monday morning to discuss “corporate update”: Sounds ominous. Glad I don’t own any.

LOL. I assume you saw Brad Loncar's Tweet:

POLL: Kite Pharma's update on Monday will be:

*Confirmation of very bad news.
*Calm down, everything is OK.

[lgonber]

Cowen analyst: Schmidt believes the weakness was due to the unsubstantiated possibility of a patient death in the lead-in portion of the Ph I/II trial in DLBCL.

"We believe it likely that such a patient would have died due to circumstances unrelated to therapy (these are very sick patients)," Schmidt commented. "Nonetheless, Kite is "excited" to present data from Ph I at ASH and is on track to start Ph II in H2."